MBX Biosciences Inc. Common Stock (MBX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    MBX Biosciences Inc. Comm...

    NASDAQ: MBX · Real-Time Price · USD
    16.69
    -0.06 (-0.36%)
    At close: Oct 03, 2025, 3:59 PM
    16.57
    -0.72%
    After-hours: Oct 03, 2025, 06:44 PM EDT

    MBX Biosciences Common Stock Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Net Income
    		 -61.92M -32.56M -26.14M
    Depreciation & Amortization
    		 244K 157K 56K
    Stock-Based Compensation
    		 5.22M 2.04M 306K
    Other Working Capital
    		 670K -1.15M 619K
    Other Non-Cash Items
    		 -2.82M -880K 1.36M
    Deferred Income Tax
    		 n/a n/a n/a
    Change in Working Capital
    		 4.6M -735K 1.29M
    Operating Cash Flow
    		 -54.68M -31.98M -23.12M
    Capital Expenditures
    		 -874K -129K -441K
    Cash Acquisitions
    		 n/a n/a n/a
    Purchase of Investments
    		 -239.47M -63.8M -20.22M
    Sales Maturities Of Investments
    		 79.75M 33M 9.25M
    Other Investing Acitivies
    		 n/a n/a n/a
    Investing Cash Flow
    		 -160.59M -30.93M -11.41M
    Debt Repayment
    		 n/a n/a 10M
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 -3.94M 709K -428K
    Financial Cash Flow
    		 234.1M 69.22M 46.06M
    Net Cash Flow
    		 18.83M 6.31M 11.53M
    Free Cash Flow
    		 -55.55M -32.11M -23.56M

    Add to Watchlist